- Roger Pebody | 19 September 2016
Dedicated efforts are needed to engage transgender men and
women with clinical services and to encourage them to use pre-exposure prophylaxis (PrEP), Asa Radix of
the Callen-Lorde Community Health Center in New ...
- Theo Smart | 13 September 2016
Non-communicable diseases (NCDs) – including cardiovascular diseases,
diabetes, cancers, and other illnesses – will represent a significant challenge
for HIV care in low- and middle-income countries as the population of people on
- Liz Highleyman | 05 September 2016
On 1 September the San Francisco Department of Public
Health released its HIV Epidemiology Annual Report 2015, showing that
the number of newly diagnosed HIV infections has continued to fall and people
- Roger Pebody | 02 September 2016
An updated adherence analysis from the ASPIRE study
indicates that consistent users of a vaginal ring containing dapivirine experienced
65% fewer infections, the 21st
International AIDS Conference (AIDS 2016) in Durban, South Africa
heard in July. ...
- Liz Highleyman | 01 September 2016
Women in San Francisco and New York
City frequently chose to use Truvada
for pre-exposure prophylaxis (PrEP) when it was offered as an additional tool
for preventing HIV infection during the pre-conception period, ...
- Roger Pebody | 31 August 2016
A significant proportion of people living with HIV would be
willing to take part in a study towards a cure for HIV, research presented at
the 21st International AIDS
Conference (AIDS 2016) in Durban, South ...
- Gus Cairns | 27 August 2016
What was described
at the 21st International AIDS Conference (AIDS 2016) as “the first PrEP trial devised and run by four
black gay men” has shown that high levels of PrEP (pre-exposure ...
- Theo Smart | 25 August 2016
“Prisoners are among
the most neglected of the key populations; they bear higher burdens of HIV,
viral hepatitis and tuberculosis than in the communities from which they come,”
said Professor Chris Beyrer of ...
- Theo Smart | 23 August 2016
The World Health Organization (WHO) has released a new
diagnostic algorithm in order to reduce the likelihood of ‘seriously ill’
people with HIV dying of undiagnosed and untreated tuberculosis (TB).
“Despite being ...
- Roger Pebody | 19 August 2016
Men who have sex with men living in African countries have
an extremely high burden of HIV, Stefan Baral of Johns Hopkins University
reminded delegates at the 21st
International AIDS Conference (AIDS 2016) in Durban, ...
- Liz Highleyman | 16 August 2016
with HIV and hepatitis B virus (HBV) co-infection have more than double the
risk of death if they have ongoing high-level HBV replication, indicating a
need for prompt treatment, according to an ...
- Liz Highleyman | 15 August 2016
Overgrowth of a certain species of vaginal bacteria
was associated with a 13-fold higher likelihood of acquiring HIV,
while another species was found to lower tenofovir levels and may contribute to
reduced efficacy ...
- Liz Highleyman | 11 August 2016
A community-based sexual health clinic in San
Francisco has offered nurse-led pre-exposure prophylaxis (PrEP) services to
more than 1200 clients and has seen no HIV infections to date, according to a
presentation last ...
- Liz Highleyman | 10 August 2016
Participants in the START treatment-timing trial who took antiretroviral
regimens containing efavirenz had an increased risk of suicidal and
self-injuring behaviour than those not using efavirenz, though the number of
events was small ...
- Theo Smart | 09 August 2016
conducted in a cohort of hospitalised adults with HIV-associated tuberculosis (TB) co-infection from
Khayelitsha found that having a detectable cytomegalovirus (CMV) viral load was associated with
higher mortality within the first ...
- Keith Alcorn | 08 August 2016
A package of enhanced prophylaxis against infections
significantly reduced the risk of death in adults and children with advanced
HIV disease after starting antiretroviral treatment in a randomised study,
Professor James Hakim of ...
- Liz Highleyman | 05 August 2016
AbbVie's paritaprevir-based 3D regimen for hepatitis C virus (HCV)
genotype 1 and 2D regimen for genotype 4 were shown to be highly effective and
well tolerated for HIV-positive people with HCV co-infection ...
- Liz Highleyman | 04 August 2016
Starting antiretroviral therapy (ART) soon
after HIV diagnosis led to better outcomes than delayed treatment in all
population sub-groups in the START trial, researchers reported at the 21st International AIDS Conference (AIDS ...
- Theo Smart | 02 August 2016
Intensified tuberculosis case finding (TB ICF) by community health
workers was associated with a dramatic (20-fold) increase in TB case detection at
a very busy antiretroviral therapy (ART) clinic in rural Malawi, ...
- Gus Cairns | 01 August 2016
patient’, Timothy Ray Brown, has now survived seven years off antiretroviral therapy
with no sign of HIV reappearing in his body, and as time passes his position
as ‘the person cured ...